PT80252A - IMPLANTABLE PREPARATIONS OF REGULATORY PEPTIDES WITH CONTROLLED RELEASE AND PROCESS FOR THEIR PREPARATION - Google Patents

IMPLANTABLE PREPARATIONS OF REGULATORY PEPTIDES WITH CONTROLLED RELEASE AND PROCESS FOR THEIR PREPARATION

Info

Publication number
PT80252A
PT80252A PT80252A PT8025285A PT80252A PT 80252 A PT80252 A PT 80252A PT 80252 A PT80252 A PT 80252A PT 8025285 A PT8025285 A PT 8025285A PT 80252 A PT80252 A PT 80252A
Authority
PT
Portugal
Prior art keywords
preparation
controlled release
regulatory peptides
implantable preparations
implantable
Prior art date
Application number
PT80252A
Other languages
German (de)
Portuguese (pt)
Other versions
PT80252B (en
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of PT80252A publication Critical patent/PT80252A/en
Publication of PT80252B publication Critical patent/PT80252B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
PT80252A 1984-04-11 1985-04-09 IMPLANTABLE PREPARATIONS OF REGULATORY PEPTIDES WITH CONTROLLED RELEASE AND PROCESS FOR THEIR PREPARATION PT80252B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843413608 DE3413608A1 (en) 1984-04-11 1984-04-11 IMPLANTABLE PREPARATIONS OF REGULATORY PEPTIDES WITH CONTROLLED RELEASE AND METHOD FOR THE PRODUCTION THEREOF

Publications (2)

Publication Number Publication Date
PT80252A true PT80252A (en) 1985-05-01
PT80252B PT80252B (en) 1987-02-03

Family

ID=6233259

Family Applications (1)

Application Number Title Priority Date Filing Date
PT80252A PT80252B (en) 1984-04-11 1985-04-09 IMPLANTABLE PREPARATIONS OF REGULATORY PEPTIDES WITH CONTROLLED RELEASE AND PROCESS FOR THEIR PREPARATION

Country Status (12)

Country Link
EP (1) EP0158277A3 (en)
JP (1) JPS60228411A (en)
KR (1) KR850007559A (en)
AU (1) AU4105985A (en)
DE (1) DE3413608A1 (en)
DK (1) DK162385A (en)
ES (1) ES8607732A1 (en)
GR (1) GR850905B (en)
HU (1) HUT40760A (en)
IL (1) IL74848A0 (en)
PT (1) PT80252B (en)
ZA (1) ZA852639B (en)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5137874A (en) * 1985-07-29 1992-08-11 American Cyanamid Co. Partially coated C10 -C20 fatty acid salts of peptides having molecular weights up to about 5,000
IL79134A (en) * 1985-07-29 1991-06-10 American Cyanamid Co Continuous release peptide implants for parenteral administration
US4892742A (en) * 1985-11-18 1990-01-09 Hoffmann-La Roche Inc. Controlled release compositions with zero order release
CA1257199A (en) * 1986-05-20 1989-07-11 Paul Y. Wang Preparation containing bioactive macromolecular substance for multi-months release in vivo
AU601736B2 (en) * 1986-05-23 1990-09-20 Sanofi Sante Nutrition Animale Sa Coated veterinary implants
AU2902289A (en) * 1987-12-08 1989-07-05 Mark Chasin Method of forming bioerodible implants for improved controlled drug release
JP2590358B2 (en) * 1988-03-01 1997-03-12 正雄 五十嵐 In utero or vaginal administration preparation for endometriosis treatment
EP0550436A1 (en) * 1989-11-06 1993-07-14 Alkermes Controlled Therapeutics, Inc. Protein microspheres and methods of using them
CA2046830C (en) * 1990-07-19 1999-12-14 Patrick P. Deluca Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer
CA2170641C (en) 1993-08-30 2011-11-15 James R. Smith Senescent cell-derived inhibitors of dna synthesis
US5599535A (en) * 1995-06-07 1997-02-04 Regents Of The University Of California Methods for the cyto-protection of the trabecular meshwork
US5674888A (en) * 1995-06-07 1997-10-07 University Of California Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
US6020473A (en) 1995-08-25 2000-02-01 Genentech, Inc. Nucleic acids encoding variants of vascular endothelial cell growth factor
US7005505B1 (en) 1995-08-25 2006-02-28 Genentech, Inc. Variants of vascular endothelial cell growth factor
US6100071A (en) 1996-05-07 2000-08-08 Genentech, Inc. Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production
JP3860841B2 (en) * 1996-08-30 2006-12-20 ペプテック リミテッド Sustained peptide release formulation
US6475724B1 (en) 1997-01-28 2002-11-05 The Regents Of The University Of California Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US6171788B1 (en) 1997-01-28 2001-01-09 The Regents Of The University Of California Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US7138511B1 (en) 1997-01-28 2006-11-21 The Regents Of The University Of California Nucleic acids, kits and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
EP2050762A3 (en) 1998-03-10 2009-07-08 Genentech, Inc. Human cornichon-like protein and nucleic acids encoding it
US7078382B1 (en) 1999-11-02 2006-07-18 Genentech, Inc. Modulation of eNOS activity and therapeutic uses thereof
US20040224000A1 (en) * 2003-05-05 2004-11-11 Romano Deghenghi Implants for non-radioactive brachytherapy of hormonal-insensitive cancers
CN103356636A (en) 2004-05-23 2013-10-23 杰勒德·M·豪斯 Theramutein modulators
US8431110B2 (en) 2005-05-23 2013-04-30 Hmi Medical Innovations, Llc. Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators
EP2322552B1 (en) 2005-06-21 2016-02-10 Xoma (Us) Llc IL-1beta binding antibodies and fragments thereof
EP1981560B1 (en) * 2006-01-05 2010-09-08 Med Institute, Inc. Zein coated medical device
CN103405768A (en) 2006-12-20 2013-11-27 爱克索马技术有限公司 Methods for the treatment of IL-1[beta] related diseases
EP2190448B1 (en) 2007-06-22 2016-04-20 Children's Medical Center Corporation Methods and uses thereof of a fragment of saposin a
EP2214747A2 (en) 2007-11-20 2010-08-11 Cook Incorporated Controlled drug delivery using a zein layer modified with levulinic acid
EP2391650B1 (en) 2007-12-20 2014-10-15 Xoma (Us) Llc Methods for the treatment of gout
WO2010144797A2 (en) 2009-06-12 2010-12-16 Vaccine Technologies, Incorporated Influenza vaccines with enhanced immunogenicity and uses thereof
CN101669899B (en) * 2009-09-29 2011-02-02 河北科技大学 Sustained-release implant taking maize protein as main framework material or matrix and use thereof
EP3366695B1 (en) 2009-12-17 2021-07-07 Children's Medical Center Corporation Saposin-a derived peptides and uses thereof
EP3165531B1 (en) 2010-03-12 2020-11-25 Children's Medical Center Corporation Immunogenic composition, vaccine, and uses thereof
CN101843577A (en) * 2010-04-08 2010-09-29 安徽中医学院 Coating implant using zein as skeleton material and preparation method
EP2579892A2 (en) 2010-06-09 2013-04-17 Vaccine Technologies, Incorporated Therapeutic immunization in hiv infected subjects receiving stable antiretroviral treatment
WO2012092539A2 (en) 2010-12-31 2012-07-05 Takeda Pharmaceutical Company Limited Antibodies to dll4 and uses thereof
ES2864764T3 (en) 2011-05-11 2021-10-14 Childrens Medical Center Immunogenic composition presenting multiple antigens, and its methods and uses
EP2744508B1 (en) 2011-08-19 2017-11-08 Children's Medical Center Corporation Vegf-binding protein for blockade of angiogenesis
US20150017157A1 (en) 2011-12-19 2015-01-15 Xoma (Us) Llc Methods for treating acne
EP3560509B1 (en) 2011-12-22 2024-01-31 Children's Medical Center Corporation Saposin-a derived peptides and uses thereof
US10774132B2 (en) 2012-01-09 2020-09-15 The Scripps Research Instittue Ultralong complementarity determining regions and uses thereof
AU2013208007A1 (en) 2012-01-09 2014-07-31 The Scripps Research Institute Humanized antibodies with ultralong CDR3
CA2900008A1 (en) 2013-02-07 2014-08-14 Children's Medical Center Corporation Protein antigens that provide protection against pneumococcal colonization and/or disease
CN105814074B (en) 2013-07-18 2020-04-21 图鲁斯生物科学有限责任公司 Humanized antibodies with ultralong complementarity determining regions
US20160168231A1 (en) 2013-07-18 2016-06-16 Fabrus, Inc. Antibodies with ultralong complementarity determining regions
JP6822839B2 (en) 2013-09-13 2021-01-27 ザ・スクリップス・リサーチ・インスティテュート Modified therapeutic agents and their compositions
EP3057991B8 (en) 2013-10-15 2019-09-04 The Scripps Research Institute Chimeric antigen receptor t cell switches and uses thereof
AU2014337367B2 (en) 2013-10-15 2020-04-30 The Scripps Research Institute Peptidic chimeric antigen receptor T cell switches and uses thereof
CN106456589B (en) 2013-12-18 2020-07-07 斯克利普斯研究所 Modified therapeutic agents, conjugated peptide lipid conjugates and compositions thereof
EP2977758A1 (en) 2014-07-24 2016-01-27 Université De Nice Sophia Antipolis Methods and kits for monitoring membranous nephropathy
WO2016154621A1 (en) 2015-03-26 2016-09-29 The California Institute For Biomedical Research SWITCHABLE NON-scFv CHIMERIC RECEPTORS, SWITCHES, AND USES THEREOF
US11091546B2 (en) 2015-04-15 2021-08-17 The Scripps Research Institute Optimized PNE-based chimeric receptor T cell switches and uses thereof
EP3310376A4 (en) 2015-06-17 2019-01-23 The California Institute for Biomedical Research Modified therapeutic agents and compositions thereof
KR20230172612A (en) 2016-10-19 2023-12-22 더 스크립스 리서치 인스티튜트 Chimeric antigen receptor effector cell switches with humanized targeting moieties and/or optimized chimeric antigen receptor interacting domains and uses thereof
KR20220061977A (en) 2019-08-12 2022-05-13 퓨리노미아 바이오테크, 아이엔씨. Methods and compositions for promoting and enhancing T cell mediated immune response through ADCC targeting of CD39 expressing cells
CA3158893A1 (en) 2019-10-24 2021-04-29 Minotaur Therapeutics, Inc. Chimeric cytokine modified antibodies and methods of use thereof
AU2022264339A1 (en) 2021-04-28 2023-11-09 Minotaur Therapeutics, Inc. Humanized chimeric bovine antibodies and methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE184774C (en) *
US2895880A (en) * 1955-05-13 1959-07-21 Smith Kline French Lab Sustained release pharmaceutical product
GB935672A (en) * 1960-07-19 1963-09-04 Sterling Drug Inc Sustained release tablet
DE2242844A1 (en) * 1972-08-31 1974-04-11 Wolfgang Joachim Guettner Zein-based aerosol spray - contg carbon dioxide propellant dissolved in solvent (mixt) for zein
HUT35524A (en) * 1983-08-02 1985-07-29 Hoechst Ag Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance

Also Published As

Publication number Publication date
DK162385A (en) 1985-10-12
ES542045A0 (en) 1986-06-01
PT80252B (en) 1987-02-03
IL74848A0 (en) 1985-07-31
ZA852639B (en) 1985-11-27
EP0158277A3 (en) 1987-04-29
DK162385D0 (en) 1985-04-10
KR850007559A (en) 1985-12-07
DE3413608A1 (en) 1985-10-24
JPS60228411A (en) 1985-11-13
HUT40760A (en) 1987-02-27
ES8607732A1 (en) 1986-06-01
GR850905B (en) 1985-11-25
EP0158277A2 (en) 1985-10-16
AU4105985A (en) 1985-10-17

Similar Documents

Publication Publication Date Title
PT80252A (en) IMPLANTABLE PREPARATIONS OF REGULATORY PEPTIDES WITH CONTROLLED RELEASE AND PROCESS FOR THEIR PREPARATION
EP0243929A3 (en) Polypeptide and protein derivatives and process for their preparation
PT79007A (en) REGULATORY PEPTIDES CONTAINING PHARMACEUTICAL PREPARATIONS WITH PRESENT RELEASE AND METHOD FOR THE PRODUCTION THEREOF
DE19375046I2 (en) 1,2,3,9-Tetrahydro-3-Ä (1H-imidazol-1-yl) methylÜ-4H-carbazol-4-one Process for their preparation and pharmaceutical preparations containing them
CY1703A (en) Substituted a-amino acids their preparation and pharmaceutical compositions containing them
DE58907887D1 (en) Carbonic acid esters of polysaccharides and process for their preparation.
PT80890A (en) MICRO-CAPSULES OF REGULATORY PEPTIDES WITH KINTROLLED RELEASE PROCESS FOR THEIR PREPARATION AND INJECTION PREPARATIONS
DE68928527D1 (en) Composition containing albumin and process for its preparation
PT73916A (en) Process for preparing 1-carboxy-aza-alkanoyl-indoline-2- carboxylic acids pharmaceutical preparations containing these compounds and their therapeutic application
IL77534A (en) Growth hormone-releasing peptides and process for their preparation
EP0362758A3 (en) Electro-insertion of proteins into animal cell membranes
PT81436A (en) ANTIBIOTIC POLYPEPTIDE PROCESS FOR ITS PREPARATION AND ITS USE
PT74129B (en) 3,4-BIS-SUBSTITUTED 1,2,5-OXDIAZOLE-2-OXIDE PROCESS FOR THEIR PREPARATION AND ITS USE OF PHARMACEUTICAL PREPARATIONS
GB2219965B (en) Matt artificial hair method of preparation thereof
GB2190594B (en) Artificial hair for hair implantation and method of preparation thereof
DE69322127T2 (en) Process for the preparation of peptide derivatives and their salts
JPS6455181A (en) Artificial protein having particular amino acid composition and method for preparation thereof
PT72899A (en) Monohydrated isophthalic acid picolylamide process of preparation and pharmaceutical use thereof
PT83869B (en) PROCESS FOR PREPARING N-CYANO-N: -METHYL-N :: -] 2 -]] (5-METHYL-1H-IMIDAZOLE-4-YL) METHYL "THIO" ETHYL "GUANIDIN
PT81408A (en) Process for the preparation of new peptides having activity in the factor of growth and sequence of the nucleic acid which classifies the peptides
ZA847975B (en) Beta-elemonic acid and pharmaceutical preparations
KE3521A (en) 2-methoxyphenyl esters of n-substituted amino acids,their preparation and pharmaceutical use
DE68926487D1 (en) Vermiculite dispersions and process for their preparation
BG43444A1 (en) Peptides and method for their preparation
BG45618A1 (en) Semicarbasides of 4- chlorphenoxiacete acid and method for their preparing

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19880803